Research Topics
| G DangasSummaryAffiliation: Cardiovascular Research Foundation Country: USA Publications
| Collaborators
|
Detail Information
Publications
Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial)George Dangas
Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
Am J Cardiol 94:983-8. 2004..The incidence of early thrombosis after primary angioplasty and stenting is decreased by abciximab use...
Transient contrast encephalopathy after carotid artery stentingG Dangas
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
J Endovasc Ther 8:111-3. 2001..To report an unusual case of transient contrast encephalopathy arising after carotid artery stenting...
Effectiveness of the concomitant use of bivalirudin and drug-eluting stents (from the prospective, multicenter BivAlirudin and Drug-Eluting STents [ADEST] study)George Dangas
Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 96:659-63. 2005....
Prognostic importance of myonecrosis after percutaneous coronary interventionsG Dangas
Cardiovascular Research Foundation, New York, NY, USA
J Invasive Cardiol 13:247-50; discussion 266-70. 2001..Data have correlated this phenomenon with late mortality, and with diffuse atherosclerotic disease. While controversy still exists, the potential for improved mortality after PCI should be fully explored in a systematic way...
Carotid artery stenting in patients with high-risk anatomy for carotid endarterectomyG Dangas
Knox Hill Heart and Vascular Institute, Cardiovascular Research Foundation, New York, New York 10022, USA
J Endovasc Ther 8:39-43. 2001..To report the results of carotid artery stenting (CAS) in patients considered to have high-risk anatomical characteristics for carotid endarterectomy...
Postprocedure creatine kinase-MB elevation and baseline left ventricular dysfunction predict one-year mortality after percutaneous coronary interventionGeorge Dangas
Cardiovascular Research Foundation, New York, New York 10022, USA
Am J Cardiol 89:586-9. 2002
Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variablesGeorge Dangas
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA
Am J Cardiol 95:13-9. 2005..22 to 2.60). Thus, regardless of the presence of CKD, baseline characteristics and periprocedural hemodynamic parameters predict CIN, and this complication is associated with worse in-hospital and 1-year outcomes...
Acute and long-term results of treatment of diffuse in-stent restenosis in aortocoronary saphenous vein graftsG Dangas
Cardiovascular Research Foundation, New York, New York 10022, USA
Am J Cardiol 86:777-9, A6. 2000..However, this population has high long-term mortality and frequent need for repeat revascularization...
Intravascular ultrasound-guided renal artery stentingG Dangas
Cardiovascular Research Foundation, New York, New York 10022, USA
J Endovasc Ther 8:238-47. 2001..To evaluate the clinical outcomes of patients undergoing renal artery stenting with intravascular ultrasound (IVUS) guidance and compare measurements between IVUS and angiography...
Pulmonary hemorrhage during GP IIb/IIIa inhibitor therapy: an uncommon but life-threatening (and under-recognized) complicationGeorge Dangas
Lenox Hill Heart and Vascular Institute, Cardiovascular Research Foundation, 55 East 59th Street, 6th Floor, New York, NY 10022, USA
J Invasive Cardiol 15:189-90. 2003
Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary interventionIoannis Iakovou
Lenox Hill Heart and Vascular Institute and Cardiovascular Research Foundation, 55 East 59th Street, 6th Floor, New York, NY, 10022, USA
J Invasive Cardiol 15:18-22. 2003..Contrast-induced nephropathy (CIN) is a recognized complication after percutaneous interventions (PCI). We sought to determine the impact of gender on incidence and clinical outcome of CIN...
Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trialGeorge Dangas
Columbia University Medical Center, New York, New York Cardiovascular Research Foundation, New York, New York 10022, USA
J Am Coll Cardiol 54:1438-46. 2009....
Cardiology patient page. Restenosis: repeat narrowing of a coronary artery: prevention and treatmentGeorge Dangas
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, NY 10022, USA
Circulation 105:2586-7. 2002
Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trialRoxana Mehran
Columbia University Medical Center New York Presbyterian Hospital and the Cardiovascular Research Foundation, New York, NY, USA
Lancet 374:1149-59. 2009..Here, we assess whether these initial benefits were maintained at 1 year of follow-up...
Bivalirudin during primary PCI in acute myocardial infarctionGregg W Stone
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10022, USA
N Engl J Med 358:2218-30. 2008..The safety and efficacy of bivalirudin in high-risk patients are unknown...
Influence of gender on early and one-year clinical outcomes after saphenous vein graft stentingJ M Ahmed
Cardiovascular Research Foundation, New York, New York 10022, USA
Am J Cardiol 87:401-5. 2001....
Gender differences in blood thrombogenicity in hyperlipidemic patients and response to pravastatinG Dangas
Cardiovascular Institute, Mount Sinai Medical Center, New York, New York, USA
Am J Cardiol 84:639-43. 1999..Blood thrombogenicity was reduced with pravastatin in both genders; in addition, thrombin generation was gradually reduced in women to a level similar to that of men by 6 months of follow-up...
Combination therapy with aspirin plus clopidogrel versus aspirin plus ticlopidine for prevention of subacute thrombosis after successful native coronary stentingG Dangas
Cardiovascular Research Foundation, New York, New York 10022, USA
Am J Cardiol 87:470-2, A7. 2001..At 30-day follow-up, there were trends toward increased subacute thrombosis with A+C compared with A+T (1.3% vs 0.2%, p = 0.10). These results suggest that A+C may have marginally higher subacute stent thrombosis than A+T...
Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarctionGregg W Stone
Columbia University Medical Center and New York Presbyterian Hospital and the Cardiovascular Research Foundation, New York, NY 10022, USA
N Engl J Med 360:1946-59. 2009....
Treatment of focal in-stent restenosis with balloon angioplasty alone versus stenting: Short- and long-term resultsR Mehran
Cardiovascular Research Foundation, 55 E 59th St, New York, NY 10022, USA
Am Heart J 141:610-4. 2001..2-4.7, P =.01). CONCLUSION: Repeat stenting for the treatment of focal ISR had a higher postprocedure creatine kinase myocardial band elevation rate and similar long-term clinical results compared with PTCA alone...
Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial)Kenichi Tsujita
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 105:1385-94. 2010..Paradoxically, in this post hoc analysis, the reductions in major bleeding and mortality in ST elevation myocardial infarction afforded by bivalirudin occurred primarily in patients without baseline anemia...
Rotational atherectomy for in-stent restenosis: acute and long-term results of the first 100 casesS K Sharma
Cardiac Catheterization Laboratory of the Zena and Michael A Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, New York 10029 6574, USA
J Am Coll Cardiol 32:1358-65. 1998....
Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patientsG W Stone
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York City, NY, USA
Circulation 104:642-7. 2001..Large periprocedural infarctions (signified by new Q waves and CPK-MB >8xULN) are powerful determinants of death, whereas lesser degrees of CPK-MB release and specific device use do not adversely affect survival...
Intra-arterial reteplase for the treatment of acute limb ischemiaJ R Laird
Cardiovascular Research Foundation, 110 Irving Street N W, Suite 4B 1, Washington, D C 20010, USA
J Invasive Cardiol 11:757-62. 1999..We report two cases of successful treatment of acute, limb threatening ischemia with intra-arterial Reteplase therapy...
An evaluation of fluoroscopy time and correlation with outcomes after percutaneous coronary interventionEugenia Nikolsky
Columbia University Medical Center and the Cardiovascular Research Foundation, New York City, NY 10022, USA
J Invasive Cardiol 19:208-13. 2007..We evaluated short-term prognosis and resource utilization of consecutive patients treated with percutaneous coronary intervention (PCI) as a function of fluoroscopy time...
Relation between preintervention remodeling and late arterial responses to coronary angioplasty or atherectomyG S Mintz
Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 87:392-6. 2001..This may explain that the increased clinical restenosis after positive remodeling lesions is treated with non-stent interventions...
Effect of percutaneous coronary interventions for in-stent restenosis in degenerated saphenous vein grafts without distal embolic protectionDale T Ashby
Lenox Hill Heart and Vascular Institute, New York, New York, USA
J Am Coll Cardiol 41:749-52. 2003..It appears that distal embolic protection may not be necessary during PCI of ISR lesions in degenerated SVGs...
Successful use of the frontrunner catheter in the treatment of in-stent coronary chronic total occlusionsYi-ming Yang
Columbia University Medical Center and Cardiovascular Research Foundation, 161 Fort Washington Avenue, New York, NY 10032, USA
Catheter Cardiovasc Interv 63:462-8. 2004..TIMI 3 flow was achieved in all target vessels after further balloon angioplasty or stenting. The Frontrunner device is a safe and effective tool in the treatment of CTOs from ISR...
Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devicesG Dangas
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA
J Am Coll Cardiol 38:638-41. 2001..5 vs. 1.5%, p = 0.03). CONCLUSIONS: In this early experience with ACD after PCI, their use was associated with higher vascular complication rates than hemostasis with manual compression...
Comparison of the angiographic outcomes after beta versus gamma vascular brachytherapy for treatment of in-stent restenosisKazuyuki Shirai
Cardiovascular Research Foundation, Lenox Hill Hospital, New York, New York 10022, USA
Am J Cardiol 92:1409-13. 2003..In matched lesions, beta and gamma VBT achieved similar reductions in treated segment restenosis and recurrent lesion length compared with placebo...
Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound studyKenichi Fujii
Cardiovascular Research Foundation, Columbia University Medical Center, 55 East 59th Street, New York, NY 10022, USA
J Am Coll Cardiol 45:995-8. 2005..03) and a significant residual reference segment stenosis (p = 0.02). CONCLUSIONS: Stent underexpansion and residual reference segment stenosis are associated with stent thrombosis after successful SES implantation...
Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound studyIoannis Iakovou
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
J Am Coll Cardiol 42:1900-5. 2003..Increased periprocedural CK-MB release appears as a trade-off for optimal stent implantation and lower clinical restenosis...
Intravascular brachytherapy for native coronary ostial in-stent restenotic lesionsCostantino O Costantini
Cardiovascular Research Foundation, Lenox Hill Hospital, 55 East 59th Street, 6th Floor, New York, New York, NY 10022, USA
J Am Coll Cardiol 41:1725-31. 2003..Vascular brachytherapy with either gamma or beta sources results in significant and similar reductions in restenosis compared with placebo. Similar benefits after VBT prevail in true aorto-ostial lesions...
Comparison of Bivalirudin versus Bivalirudin plus glycoprotein IIb/IIIa inhibitor versus heparin plus glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes having percutaneous intervention for narrowed saphenous vein aorto-coronary graDinesh Kumar
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 106:941-5. 2010....
Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasoundMasashi Kimura
The Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 98:436-42. 2006..Although most ISAs after SES implantation do not resolve completely, the incidence of restenosis or thrombosis is not affected...
Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent eraTereza Pucelikova
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY, USA
Am J Cardiol 101:63-8. 2008..025). In conclusion, our data show that patients with SVG lesions remain a high-risk subgroup with worse outcomes after percutaneous coronary intervention compared with native vessel disease even in the era of drug-eluting stents...
Comparison of clinical outcomes using stents versus no stents after percutaneous coronary intervention for proximal left anterior descending versus proximal right and left circumflex coronary arteriesDale T Ashby
Cardiovascular Research Foundation, Lenox Hill Heart and Vascualr Institute, New York, New York 10022, USA
Am J Cardiol 89:1162-6. 2002..A stenting strategy for proximal LAD stenoses appears to attenuate the differences of clinical restenosis noted after non-stent PCI...
Gender differences in clinical outcome after coronary artery stenting with use of glycoprotein IIb/IIIa inhibitorsIoannis Iakovou
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Am J Cardiol 89:976-9. 2002
Pravastatin: an antithrombotic effect independent of the cholesterol-lowering effectG Dangas
Cardiovascular Institute, Mount Sinai Medical Center, Cardiovascular Research Foundation, New York, NY 10022, USA
Thromb Haemost 83:688-92. 2000..Therefore, the reduction in thrombogenicity was not proportional to the magnitude of LDL-C reduction suggesting that a class or agent specific property is primarily responsible for the pro-fibrinolytic/antithrombotic effects observed...
Novel site-specific systemic delivery of Rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in a porcine coronary restenosis modelNicholas N Kipshidze
Department of Interventional Cardiac and Vascular Services, Lenox Hill Hospital, New York, NY 10021, USA
Catheter Cardiovasc Interv 64:389-94. 2005..001). In the porcine coronary model, site-specific systemic delivery of Rapamycin utilizing PGMC resulted in overexpression of p27 and a significant reduction of neointimal formation within the stented segments...
Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosisKenichi Fujii
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, NY 10021, USA
Circulation 109:1085-8. 2004..03). A gap between SESs was identified in 3 of 11 recurrences versus 1 of 19 nonrecurrent lesions. CONCLUSIONS: Stent underexpansion is a significant cause of failure after SES implantation treatment of ISR...
Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis modelNicholas N Kipshidze
Lenox Hill Heart and Vascular Institute and Cardiovascular Research Foundation, New York, New York 10021, USA
Catheter Cardiovasc Interv 61:518-27. 2004..In the porcine coronary model, an advanced c-myc-eluting PC stent blocked c-myc expression and significantly inhibited myointimal hyperplasia and allowed complete reendothelialization and healing response...
Minimally invasive direct coronary artery bypass (MIDCAB) versus coronary artery stenting for elective revascularization of the left anterior descending arteryIoannis Iakovou
Cardiovascular Research Foundation, New York, New York 10022, USA
Am J Cardiol 90:885-7. 2002
Creatine kinase-MB enzyme elevation and long-term clinical events after successful coronary stenting in lesions with ruptured plaqueKenichi Fujii
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA
Am J Cardiol 95:355-9. 2005..Plaque rupture morphology is associated with higher periprocedural CK-MB release and worse 1-year clinical outcome in patients treated with coronary stenting...
A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validationRoxana Mehran
Cardiovascular Research Foundation, Columbia University Medical Center, New York, New York 10022, USA
J Am Coll Cardiol 44:1393-9. 2004..4% to 55.9% for a low and high risk score, respectively). CONCLUSIONS: The risk of CIN after PCI can be simply assessed using readily available information. This risk score can be used for both clinical and investigational purposes...
Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus-eluting stentsEugenia Nikolsky
Columbia University Medical Center, Center for Interventional Vascular Therapy and the Cardiovascular Research Foundation, New York, NY 10022, USA
Catheter Cardiovasc Interv 71:896-906. 2008..We assessed the outcomes in diabetic patients undergoing percutaneous coronary intervention (PCI) using sirolimus-eluting stents (SES) as a function of treatment with glycoprotein (GP) IIb/IIIa inhibitors...
Comparison of in-hospital and one-year outcomes after multiple coronary arterial stenting in patients > or =80 years old versus those <80 years oldYoshio Kobayashi
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Am J Cardiol 92:443-6. 2003....
Restenosis due to underexpansion of sirolimus-eluting stent in a bifurcation lesionHideo Takebayashi
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Catheter Cardiovasc Interv 60:496-9. 2003..This case report describes in-stent restenosis due to stent underexpansion after kissing stents using sirolimus-eluting stents...
The relative effects of abciximab and tirofiban on platelet inhibition and C-reactive protein during coronary interventionAdam J Saltzman
Cardiovascular Medicine and the Center for Interventional Vascular Therapy, Columbia University Medical Center, 161 Fort Washington Avenue, New York, NY, 10032, USA
J Invasive Cardiol 22:2-6. 2010..We sought to compare the efficacy of tirofiban and abciximab on platelet inhibition as well as their effects of platelet inhibition on C-reactive protein levels during percutaneous coronary intervention (PCI)...
Relation between the degree of procedural anticoagulation and complications after coronary stent implantationDale T Ashby
Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Am J Cardiol 92:319-22. 2003..High levels of procedural anticoagulation with heparin were found to increase hemorrhagic complications without improving clinical or angiographic outcomes...
Usefulness of the angiographic pattern of in-stent restenosis in predicting the success of gamma vascular brachytherapyCostantino O Costantini
Cardiovascular Research Foundation, New York, New York 10021, USA
Am J Cardiol 92:1214-7. 2003....
Bifurcation stenting with drug-eluting stents: a systematic review and meta-analysis of randomised trialsSomjot S Brar
Columbia University Medical Center, New York, NY, USA
EuroIntervention 5:475-84. 2009....
Comparison of outcomes in men versus women having percutaneous coronary interventions in small coronary arteriesDale T Ashby
Cardiovascular Research Foundation, 55 East 59th Street, 6th Floor, New York, NY 10022, USA
Am J Cardiol 91:979-81, A4, A7. 2003
The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationaleRoxana Mehran
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10032, USA
Am Heart J 156:44-56. 2008..Newer pharmacologic agents and drug-eluting stents may address both of these issues...
Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarctionGregg W Stone
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
J Am Coll Cardiol 39:591-7. 2002..We sought to evaluate and validate the ability of the angiographic myocardial blush grade to risk stratify patients after successful angioplasty in acute myocardial infarction (AMI)...
Drug-eluting stents in the real world: how intravascular ultrasound can improve clinical outcomeJeffrey W Moses
Center for Interventional Vascular Therapy, Presbyterian Hospital, Columbia University Medical Center, New York, New York, USA
Am J Cardiol 102:24J-8J. 2008..Ensuring adequate stent dimensions and wall contact can contribute to successful outcomes in patients receiving SES...
Quantitative angiographic methods for appropriate end-point analysis, edge-effect evaluation, and prediction of recurrent restenosis after coronary brachytherapy with gamma irradiationAlexandra J Lansky
Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
J Am Coll Cardiol 39:274-80. 2002....
Treatment of restenotic drug-eluting stents: an intravascular ultrasound analysisKoichi Sano
Cardiovascular Research Foundation, 611 Pennsylvania Avenue, S E, No 386, Washington, D C, USA
J Invasive Cardiol 19:464-8. 2007..The intravascular ultrasound (IVUS) findings during repeat intervention for drug-eluting stent (DES) restenosis have not been well described...
Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationaleGregg W Stone
Columbia University Medical Center, Cardiovascular Research Foundation, New York, NY 10022, USA
Am Heart J 148:764-75. 2004..Pilot trials suggest that the thrombin-specific anticoagulant bivalirudin may improve clinical outcomes in ACS...
Acute and long-term outcomes of cutting balloon angioplasty followed by gamma brachytherapy for in-stent restenosisYoshio Kobayashi
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Am J Cardiol 92:1329-31. 2003..02) but similar target vessel revascularization (35.1% vs 29.8%, p = 0.4) at follow-up...
New-device angioplasty in women: clinical outcome and predictors in a 7,372-patient registryAlexandra J Lansky
Cardiac Catheterization Laboratory and the Women s Cardiac Health Initiative, Lenox Hill Hospital, New York City, NY 10022, USA
Epidemiology 13:S46-51. 2002..To gain insight into the outcome of women after new-device angioplasty, we reviewed the early and late clinical outcome of 7,372 patients undergoing new-device angioplasty between 1991 and 1996 at the Washington Hospital Center...
Intravascular ultrasound assessment of ulcerated ruptured plaques: a comparison of culprit and nonculprit lesions of patients with acute coronary syndromes and lesions in patients without acute coronary syndromesKenichi Fujii
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, 130 East 77th St, 9th Floor, New York, NY 10021, USA
Circulation 108:2473-8. 2003..Plaque rupture itself does not lead to symptoms. The association of plaque rupture with a smaller lumen area and/or thrombus formation causes lumen compromise and leads to symptoms...
Comparison of differences in outcome after percutaneous coronary intervention in men versus women <40 years of ageAlexandra J Lansky
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Am J Cardiol 93:916-9. 2004....
Optimal final lumen area and predictors of target lesion revascularization after stent implantation in small coronary arteriesIoannis Iakovou
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Am J Cardiol 92:1171-6. 2003..Therefore, there does not appear to be any "downside" to aggressive stent implantation strategies in small vessels. In contrast, IVUS allows maximization of final lumen dimensions to minimize clinical restenosis...
Comparison of safety and efficacy between first and second generation of angio-seal closure devices in interventional patientsZoran Lasic
Department of Interventional Cardiology, Lenox Hill Hospital, 100 East 77th Street, New York, NY 10021, USA
J Invasive Cardiol 16:356-8. 2004..This study found that the new Angio-Seal STS Platform device can secure hemostasis after PCI in a safe and effective manner similar to the old device. The new platform is easier for the operator and for the patients...
Correlation of coronary arterial remodeling determined by intravascular ultrasound with angiographic diameter reduction of 20% to 60%Makoto Hirose
Cardiovascular Research Foundation, New York, NY 10021, USA
Am J Cardiol 92:141-5. 2003..7) were similar. Negative remodeling is frequently observed in lesions with intermediate stenosis. This suggests that negative remodeling occurs early in lesion formation...
One-year clinical outcome after minimally invasive direct coronary artery bypassR Mehran
Cardiovascular Research Foundation, New York, NY 10022, USA
Circulation 102:2799-802. 2000..Minimally invasive coronary artery bypass (MIDCAB) is a new surgical technique by which the left internal mammary artery is anastomosed under direct visualization to the left anterior descending artery without cardiopulmonary bypass...
Evaluation of myocardial viability in asymptomatic patients early after infarction with perfusion/metabolism single-photon-emission computed tomographic imaging and dobutamine echocardiographyG Dangas
Zena and Michael A Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY, USA
Coron Artery Dis 11:409-14. 2000..To study the impact of detection of viability of myocardium in asymptomatic patients early (3-10 days) after Q-wave myocardial infarction on segmental recovery of left ventricular function after elective revascularization...
Contrast-induced nephropathyTereza Pucelikova
Cardiovascular Research Foundation, 55 East 59th Street, 6th Floor, New York, New York 10022, USA
Catheter Cardiovasc Interv 71:62-72. 2008....
Necrotic core and its ratio to dense calcium are predictors of high-risk non-ST-elevation acute coronary syndromeEduardo Missel
Cardiovascular Research Foundation, Columbia University Medical Center, New York, NY, USA
Am J Cardiol 101:573-8. 2008..01) than patients with no predictors. In conclusion, VH-IVUS analysis showed that the percentage of NC and its ratio to DC in diseased coronary segments are positively associated with a high-risk ACS presentation...
Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysisEugenia Nikolsky
Cardiovascular Research Foundation and the Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
J Am Coll Cardiol 44:1200-9. 2004..79). CONCLUSIONS: In the setting of Dx angiography, the risk of access-site-related complications was similar for ACD compared with mechanical compression. In the setting of PCI, the rate of complications appeared higher with VasoSeal...
Long-term follow-up of patients after gamma intracoronary brachytherapy failure (from GAMMA-I, GAMMA-II, and SCRIPPS-III)Thosaphol Limpijankit
Cardiovascular Research Foundation, New York, New York 10022, USA
Am J Cardiol 92:315-8. 2003..e., drug-eluting stents) are available. Shorter time from brachytherapy to radiation failure and late thrombosis after brachytherapy were independent predictors of adverse events...
Nonrandomized comparison of coronary stenting under intravascular ultrasound guidance of direct stenting without predilation versus conventional predilation with a semi-compliant balloon versus predilation with a new scoring balloonJose de Ribamar Costa
Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
Am J Cardiol 100:812-7. 2007..In conclusion, in this observational, nonrandomized study, pretreatment with the AngioSculpt balloon enhanced stent expansion and minimized the difference between predicted and achieved stent dimensions...
Gamma radiation for in-stent restenosis: effect of lesion length on angiographic and clinical outcomesRoxana Mehran
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
Catheter Cardiovasc Interv 61:354-9. 2004..Lesion length remains a powerful predictor of recurrent ISR and clinical events after treatment of ISR even with gamma-RT...
Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary arteryGeorge Dangas
Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
J Am Coll Cardiol 45:1186-92. 2005..Notably, the need for bypass graft surgery due to restenosis is reduced after TAXUS stent implantation in LAD lesions...
Intravascular ultrasound assessment of fibrous cap remnants after coronary plaque ruptureLisette Okkels Jensen
Cardiovascular Research Foundation, New York, NY 10022, USA
Am Heart J 152:327-32. 2006....
Coronary artery stentingDale T Ashby
Cardiovascular Research Foundation, New York, New York 10022, USA
Catheter Cardiovasc Interv 56:83-102. 2002
Favorable effect of gamma-radiation for in-stent restenosis: effect of diabetes on angiographic and clinical outcomesIoannis Iakovou
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA
Catheter Cardiovasc Interv 62:303-7. 2004..DM remains a powerful predictor of TLR and major adverse cardiac events even after treatment of ISR with gamma-RT...
Intravascular ultrasonic assessment of stent diameters derived from manufacturer's compliance chartsJose de Ribamar Costa
Cardiovascular Research Foundation, New York, New York, USA
Am J Cardiol 96:74-8. 2005..These differences are independent of stent manufacturer, length, diameter, and deployment pressure...
Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventionsEugenia Nikolsky
Cardiovascular Research Foundation, New York, New York, USA
Kidney Int 67:706-13. 2005..Whether correcting the hematocrit prepercutaneous coronary intervention might decrease the rates of contrast-induced nephropathy should be addressed in a prospectively designed trial...
The role of platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary revascularization proceduresG Dangas
Zena and Michael A Wiener Cardiovascular Institute, Mount Sinai Medical Center, New York, NY, USA
Rev Port Cardiol 18:I49-53. 1999..Compelling data on the central role of platelets in arterial thrombosis have made apparent the need for more potent antiplatelet agents for the treatment of patients undergoing PCI...
Prevalence of autoantibodies against contractile proteins in coronary artery disease and their clinical implicationsG Dangas
Cardiovascular Research Foundation, New York, New York 10022, USA
Am J Cardiol 85:870-2, A6, A9. 2000..Moreover, they correlated with persistent troponin-I elevation at follow-up, and with late myocardial infarction...
Effect of short pulsed nonablative infrared laser irradiation on vascular cells in vitro and neointimal hyperplasia in a rabbit balloon injury modelN Kipshidze
Lenox Hill Heart and Vascular Institute of New York and Cardiovascular Research Foundation, New York, NY, USA
Circulation 104:1850-5. 2001..Neointimal hyperplasia after PTCA is an important component of restenosis...
Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial)Ricardo A Costa
Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York 10022, USA
Am J Cardiol 95:113-6. 2005..There was 1 in-stent and 1 in-segment (proximal edge) restenosis in the metallic stent group. There was no stent thrombosis or aneurysm formation at follow-up in either group...
Relation of final lumen dimensions in saphenous vein grafts after stent implantation to outcomeIoannis Iakovou
Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA
Am J Cardiol 93:963-8. 2004..A less aggressive stent implantation strategy in SVGs than in native coronary lesions appears prudent...
Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary interventionEmilia Solinas
Division of Cardiology, Parma University Hospital, Italy
Am J Cardiol 102:311-5. 2008..Treatment with either repeated DES implantation or balloon angioplasty for DES-ISR was safe and associated with low overall rates of target-lesion revascularization and major adverse cardiac events at 1 year...
Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stentingDeepak L Bhatt
Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA
J Am Coll Cardiol 39:9-14. 2002..Therefore, clopidogrel plus aspirin should replace ticlopidine plus aspirin as the standard antiplatelet regimen after stent deployment...
Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable angina pectoris or provocable myocardial ischemia (a TAXUS IV substudy)Paul S Teirstein
Scripps Clinic, La Jolla, California, USA
Am J Cardiol 96:500-5. 2005..By multivariate analysis, use of GP IIb/IIIa inhibitors during stenting with the TAXUS stent was an independent predictor of CK-MB increases >3 times the normal level. Further studies are warranted...
Clinical outcome following percutaneous coronary interventions in patients with chronic renal failureLuis Gruberg
Department of Cardiology, Rambam Medical Center, Haifa, Israel
Catheter Cardiovasc Interv 55:66-72. 2002..0001), and CRF (OR = 1.74; P = 0.003) were independent correlates of increased late mortality. Therefore, PCI in patients with impaired renal function, whether on dialysis or not, is associated with poor in-hospital and 1-year survival...
Editorial commentary: in-stent restenosis and cutting balloonGeorge Dangas
J Invasive Cardiol 14:297-8. 2002
Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trialsJeffrey W Moses
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10032, USA
J Am Coll Cardiol 47:2164-71. 2006....
Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approachEugenia Nikolsky
Cardiovascular Research Foundation, Columbia University Medical Center, Herbert Irving Pavilion, 5th Floor, 161 Fort Washington Avenue, New York, NY 10032, USA
Eur Heart J 28:1936-45. 2007..Major bleeding after percutaneous coronary intervention (PCI) is an independent risk factor for early and late mortality. We developed and validated a risk score predictive of major bleeding after PCI using the femoral approach...
Thrombosis after implantation of drug-eluting stentsIoannis Iakovou
Army Hospital of Thessaloniki, Greece and Euromedica, Blue Cross, Greece
Hellenic J Cardiol 47:31-8. 2006
